Artiva Biotherapeutics, Inc. ARTV Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s other operating expenses?
- Artiva Biotherapeutics, Inc. (ARTV) reported other operating expenses of $24.43M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s other operating expenses changed year-over-year?
- Artiva Biotherapeutics, Inc.'s other operating expenses increased by 10.2% year-over-year, from $22.17M to $24.43M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s other operating expenses?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s other operating expenses has grown at a 18.3% compound annual growth rate (CAGR), from $64.16M to $89.81M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.